ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Agopton 15 mg, magensaftresistente Hartkapseln - 56 Kapsel(n)
51969065 Takeda Pharma AG
Agopton 15 mg, magensaftresistente Hartkapseln18.06.1993
Original11.09.1995
Lansoprazole (A02BC03)22.11.2007
WHO-DDD 
04.99.56 Kapsel(n)
04.99. 
B  
Yes 
IPCI
20.19No
    
20 %38.20
7680519690652Synthetika
1653922 
Composition
lansoprazolum 15 mg, magnesii subcarbonas ponderosus, sacchari sphaerae, saccharum, maydis amylum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum natrii laurilsulfas, macrogolum 8000, E 171, polysorbatum 80, talcum, silica colloidalis anhydrica, Kapselhülle: gelatina, aqua, E 171, pro capsula corresp. natrium max. 0.02 mg et saccharum max. 80.3 mg.
Packungsbestandteile
  
  
 
Active AgentDose
Lansoprazole15 mg
BAG: Active AgentDose
Lansoprazole15 mg
 
Inactive agentsDoseadditional_information
   
Aqua  
  color.
   
Gelatina Kapselhülle
   
   
Macrogol8000  
Magnesii Subcarbonas Ponderosus  
   
Polysorbatum 80  
   
Saccharum  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 07.05.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home